Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / MDT - Medtronic's Patent Challenge And Other News: The Good Bad And Ugly Of Biopharma


MDT - Medtronic's Patent Challenge And Other News: The Good Bad And Ugly Of Biopharma

Medtronic Gets Patent Challenge from Axonics

Medtronic Plc (MDT) saw a small setback as Axonics Modulation Technologies filed a petition with the United States Patents and Trademark Office against one of its patents. The petitions contest the validity of Medtronic's patent related to sacral neuromodulation (SNM).

It is expected that the Patent Trial and Appeal Board will report their decision from the inter partes review ((IPR)) in the next 12 months of beginning of the process. However, the board may take up to six months to decide whether the use of IPR is

Read more ...

Stock Information

Company Name: Medtronic plc.
Stock Symbol: MDT
Market: NYSE
Website: medtronic.com

Menu

MDT MDT Quote MDT Short MDT News MDT Articles MDT Message Board
Get MDT Alerts

News, Short Squeeze, Breakout and More Instantly...